Prosecution Insights
Last updated: October 02, 2026
Application No. 18/722,260

APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT

Non-Final OA §112
Filed
Jun 20, 2024
Priority
Dec 30, 2021 — EU 21306959.4 +1 more
Examiner
KALIHER, HANS CHRISTIAN
Art Unit
3781
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Gambro Lundia AB
OA Round
1 (Non-Final)
63%
Grant Probability
Moderate
1-2
OA Rounds
10m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 63% of resolved cases
63%
Career Allowance Rate
88 granted / 140 resolved
-7.1% vs TC avg
Strong +27% interview lift
Without
With
+27.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
41 currently pending
Career history
184
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
54.1%
+14.1% vs TC avg
§102
21.9%
-18.1% vs TC avg
§112
20.0%
-20.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 140 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claim 39 recites the limitation “calculate the section pressure drop as function of…” on 7, which is interpreted to read “calculate the section pressure drop as a function of…”. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 29, 31-34, 39, and 40 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 29 states “wherein the control unit is configured to calculate the section pressure drop during at least one time the extracorporeal blood treatment” which is unclear, and therefore indefinite. For the purpose of examination, the claim is interpreted to mean “wherein the control unit is configured to calculate the section pressure drop during at least one time during the extracorporeal blood treatment” (Emphasis by Examiner). Claim 31 recites “…stopped to obtain a zero a blood flow rate” on line 3 which unclear and therefore indefinite. This is interpreted to read as “…stopped to obtain a zero Claims 32-34, 39, and 40 are rejected based on their dependency. REASONS FOR ALLOWANCE Claims 24-28, 30, 35-38, and 41-47 are allowed. Claims 32-34, 39, and 40 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is an examiner’s statement of reasons for allowance: US 20160354531 A1 (Kopperschmidt) is the closest prior art of record. Kopperschmidt teaches an apparatus for extracorporeal blood treatment, comprising: a filtration unit (2); an extracorporeal blood circuit having a blood withdrawal line (5) connected to an inlet of the filtration unit and a blood return line (7) connected to an outlet of the filtration unit, said extracorporeal blood circuit being configured for connection to a cardiovascular system of a patient (par. 36); the extracorporeal blood circuit comprising at least one connector (5a, 7a) for connection to a vascular access device (1) fixed to the patient ; at least one pressure sensor (18 arterial, 19 venous) configured to detect a pressure in at least one measurement location in the extracorporeal blood circuit (Fig. 1); a blood pump (6) configured to control the flow of blood through the extracorporeal blood circuit; a control unit (22) connected to the blood pump (6) and to the at least one pressure sensor (18,19), the control unit (22) being configured for detecting a disconnection between the at least one connector (5a, 7a) of the extracorporeal blood circuit and the vascular access device (1; paragraph 9); wherein, during an extracorporeal blood treatment, the control unit (22) is configured for: receiving a measured pressure from the at least one pressure sensor (18,19); Kopperschmidt fails to teach calculating a hydrostatic pressure difference due to a difference in height between the vascular access device, instead teaching in paragraph 43, the hydrostatic pressure difference is calculated between the venous pressure sensor and the patient's heart and said at least one pressure sensor; Additionally, Kopperschmidt fails to teach calculating a section pressure drop due to a section of the blood circuit from the connector to said at least one pressure sensor and calculating a disconnection pressure as an algebraic sum of the hydrostatic pressure difference and the section pressure drop; setting a pressure alarm threshold as a function of the disconnection pressure; and detecting a disconnection of the least one connector from the vascular access device by comparing the measured pressure with the pressure alarm threshold. The claimed steps for detecting a disconnection were not found as claimed in similar art and Kopperschmidt fails to teach or suggest the claimed steps for determining a disconnection event. Kopperschmidt therefore fails to teach the claimed device, alone or in combination. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to HANS KALIHER whose telephone number is (303)297-4453. The examiner can normally be reached Monday-Friday 08:00-05:00 MT. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sarah Al-Hashimi can be reached at (571) 272-7159. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /HANS KALIHER/Examiner, Art Unit 3781 /JESSICA ARBLE/Primary Examiner, Art Unit 3781
Read full office action

Prosecution Timeline

Jun 20, 2024
Application Filed
Aug 11, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12728029
Medical device for collection and release of bodily waste from a subject, uses and method thereof
3y 4m to grant Granted Sep 08, 2026
Patent 12708373
DEVICE, SYSTEM AND METHOD FOR INTERMITTENT DISPLACEMENT OF BLOOD TO MITIGATE PERIPHERAL NERVE NEUROPATHY
2y 5m to grant Granted Aug 18, 2026
Patent 12690998
URINE COLLECTION AND DRAINAGE APPARATUS
3y 1m to grant Granted Jul 28, 2026
Patent 12616602
BACTERIA FORMULATION AND PRODUCTS INCLUDING SAME
3y 3m to grant Granted May 05, 2026
Patent 12616604
EXTERNAL CATHETER APPARATUS
2y 5m to grant Granted May 05, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
63%
Grant Probability
90%
With Interview (+27.3%)
3y 1m (~10m remaining)
Median Time to Grant
Low
PTA Risk
Based on 140 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month